The Role of P-Glycoprotein in Transport of Danshensu across the Blood-Brain Barrier

Abstract EN

Danshensu (3-(3, 4-dihydroxyphenyl) lactic acid), a water-soluble active component isolated from the root of Salvia miltiorrhiza Bunge, is widely used for the treatment of cerebrovascular diseases.

The present study aims to investigate the role of P-glycoprotein in transport of Danshensu across the blood-brain barrier.

Sprague-Dawley rats were pretreated with verapamil at a dose of 20 mg kg−1 (verapamil group) or the same volume of normal saline (control group).

Ninety minutes later, the animals were administrated with Danshensu (15 mg kg−1) by intravenous injection.

At 15 min, 30 min, and 60 min after Danshensu administration, the levels of Danshensu in the blood and brain were detected by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS).

The results showed that Danshensu concentrations in the brain of the rats pretreated with verapamil were significantly increased.

In addition, the brain-plasma ratios of the group pretreated with verapamil were much higher than that of the control group.

There was no difference in Danshensu level in plasma between the verapamil group and control group.

The findings indicated that Danshensu can pass the blood-brain barrier, and P-glycoprotein plays an important role in Danshensu transportation in brain.